AME Equities LLC 3
3 · Chromocell Therapeutics Corp · Filed Feb 15, 2024
Insider Transaction Report
Form 3
AME Equities LLC
10% Owner
Holdings
- 351,163
Common Stock
Senior Secured Convertible Promissory Note
Exp: 2024-02-29→ Common Stock (11,876 underlying)Senior Secured Convertible Promissory Note
Exp: 2024-03-01→ Common Stock (6,138 underlying)
Footnotes (3)
- [F1]Represents $57,001.62 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which will automatically convert into 11,876 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
- [F2]Represents $29,084.97 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which will automatically convert into 6,138 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 78 shares of common stock issuable as consideration for this senior secured convertible promissory note.
- [F3]Ruth Friedman has sole voting and dispositive power over the shares held by the Reporting Person as to which Ms. Friedman disclaims beneficial ownership except to the extent of her pecuniary interest therein.